Update on the Development of Anti-Viral Agents Against Hepatitis C.

about

Update on the Development of Anti-Viral Agents Against Hepatitis C.

Item

http://www.wikidata.org/entity/Q38584271

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Update on the Development of Anti-Viral Agents Against Hepatitis C.

@en

type

Item

label

Update on the Development of Anti-Viral Agents Against Hepatitis C.

@en

prefLabel

Update on the Development of Anti-Viral Agents Against Hepatitis C.

@en

P1476

Update on the Development of Anti-Viral Agents Against Hepatitis C.

@en

P2093

Catherine H Wu

http://www.w3.org/2001/XMLSchema#string

George Y Wu

http://www.w3.org/2001/XMLSchema#string

Kristin L Macarthur

http://www.w3.org/2001/XMLSchema#string

Martina V Smolic

http://www.w3.org/2001/XMLSchema#string

Robert Smolic

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

Epidemiology of hepatitis C virus infection

An RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6, facilitate hepatitis C virus replication.

Identification of host proteins required for HIV infection through a functional genomic screen

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines

Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors

Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection

P304

9-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14218/JCTH.2013.007XX

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26357602

http://www.w3.org/2001/XMLSchema#string

P932

4521270

http://www.w3.org/2001/XMLSchema#string